Castle Biosciences (CSTL) EBIT Growth (1y) (2019 - 2026)
Castle Biosciences (CSTL) EBIT Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -130.92% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.57% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 5.49% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 14.55% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 33.00% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -18.11% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 3.63% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 27.44% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 2.57% |
| 10 | Castle Biosciences | 629.76 Mn | 368.04 Mn | 63.15 Mn | 34.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.09% |
| Dec 31, 2025 | -194.49% |
| Sep 30, 2025 | -233.96% |
| Jun 30, 2025 | -184.82% |
| Mar 31, 2025 | -410.47% |
| Dec 31, 2024 | 171.58% |
| Sep 30, 2024 | 152.69% |
| Jun 30, 2024 | 123.69% |
| Mar 31, 2024 | 82.64% |
| Dec 31, 2023 | 75.22% |
| Sep 30, 2023 | 55.24% |
| Jun 30, 2023 | -432.79% |
| Mar 31, 2023 | -28.58% |
| Dec 31, 2022 | -50.50% |
| Sep 30, 2022 | -82.29% |
| Jun 30, 2022 | 54.93% |
| Mar 31, 2022 | -472.27% |
| Dec 31, 2021 | -400.36% |
| Sep 30, 2021 | -202.85% |
| Jun 30, 2021 | -1,265.89% |